“We’re trying to design smarter cells," Stanley Qi says. Using the CRISPR gene-editing method, Qi gave certain immune cells a "homing beacon" to zero in on leukemia. His research could one day lead to treatments for Parkinson’s and other cancers.http://stanford.io/2GT2FpZ
0 replies
31 retweets
78 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.